4//SEC Filing
Huang Kelly 4
Accession 0001214659-17-005564
CIK 0001427570other
Filed
Sep 7, 8:00 PM ET
Accepted
Sep 8, 4:49 PM ET
Size
5.5 KB
Accession
0001214659-17-005564
Insider Transaction Report
Form 4
Huang Kelly
Chief Operating Officer
Transactions
- Award
Stock Option (Right to Buy)
2017-09-06+269,230→ 269,230 totalExercise: $9.31Exp: 2027-09-05→ Common Stock (269,230 underlying)
Footnotes (1)
- [F1]This option vests as to 25% of the total shares on September 6, 2018, then 2.083% monthly, with 100% of the total shares vested on September 6, 2021, subject to the reporting person's provision of service to the Issuer on each vesting date.
Documents
Issuer
OBALON THERAPEUTICS INC
CIK 0001427570
Entity typeother
Related Parties
1- filerCIK 0001602803
Filing Metadata
- Form type
- 4
- Filed
- Sep 7, 8:00 PM ET
- Accepted
- Sep 8, 4:49 PM ET
- Size
- 5.5 KB